+1-888-308-5802     
News Contact Us

Carlyle-Zydus, Advent compete for Bharat Serums and Vaccines takeover

Author : Saif Ali Bepari | Published Date : 2019-04-22 

Reports indicate that an association of Zydus Cadila and Carlyle is competing against Advent International, a global private equity group, over the acquisition of Bharat Serums and Vaccines Ltd (BSV), a Mumbai based bio-pharmaceutical company. Both the companies have submitted non-binding offers between Rs 3,450-3,600 crore (US$500-520 million).

The Daftary family, founder promoters of BSV, had supposedly anticipated a valuation of Rs 4,000-4,300 crore (US$600-630 million) for their company. The Daftary family, present investors Orbimed Asia and Kotak Private Equity are seeking to sell a majority stake in the company.

Seemingly, the two funds own a combined 23% stake and the remaining part is with the founders. However, two years ago, the company had planned Rs 2,000-crore initial public offering for giving an exit to the investors, which was called off later.

According to ET reports, in Dec 2017, the company was highly valued at Rs 6,667 crore. If this acquisition agreement goes well, then Daftary would likely retain about 35-40% stake in BSV.

Sources reported that after Heinz India’s buyout, it would be the second time that Zydus Group is looking to work with a PE partner. Zydus Wellness, a profound company of Zydus group, had acquired consumer wellness business of Heinz India including renowned brands like Glucon D and Complan. 

For the Rs 4,595-crore acquisition, Zydus had received the support of True North, a PE fund which invested around Rs 1,000 crore.

For the uninitiated, BSV is involved in selling products including antifungals, equine anti-toxins and serums, anaesthetics, cardiovascular and diagnostic products in India and also in over 45 countries. Its R&D facilities run in Germany, India, and the US.

The company also has joint venture-based and own plants in Germany’s Aachen as well as in India at Ahmedabad and Ambernath. In fiscal year 2017, the revenue of the company was Rs 620 crore with a profit of Rs 40 crore, though recent financial details are not available yet.

Source Credit: https://economictimes.indiatimes.com/industry/banking/finance/carlyle-zydus-and-advent-join-race-to-acquire-bharat-serums-and-vaccines-ltd/articleshow/68983439.cms

About Author

Saif Ali Bepari

Saif Ali Bepari

A qualified Computer Science graduate, Saif Ali Bepari, armed with more of an inclination toward writing than coding, commenced his journey in the content industry as a freelancer. Currently penning down content for fractovia.org and a couple of other portals, Saif has also tinkered with creative writing, technical writing, blog writing, and copywriting. He can be contacted at- [email protected] | https://twitter.com/Saif_B17

Related News

Garmin launches new IFR-approved GPS navigator with LPV approach

Published Date: 2019-07-20         Author: Saif Ali Bepari

Garmin International, Inc., the US based multinational technology company, has recently launched the new a new GPS navigator, GNC 355, with Localizer Performance with Vertical approach guidance, complete with a built-in Comm radio. Apparently, with the new GNC 355, pilots can take benefits of WAA... Read More

Amazon extends anti-counterfeit Transparency program beyond U.S.

Published Date: 2019-07-12         Author: Saif Ali Bepari

Amazon has recently announced that it is expanding the Transparency program, an initiative to address counterfeit problems in e-commerce, to India, Canada and Europe. Transparency is aimed at serializing products with a T-shaped QR type code to help in the identification of a counterfeit item. Vi... Read More

ABB to build collaborative robotic solutions for healthcare automation

Published Date: 2019-07-11         Author: Saif Ali Bepari

ABB has recently announced that it will launch collaborative robots for medical laboratories, with the opening of a new healthcare hub at Houston-based Texas Medical Center (TMC) facility. Apparently, the innovation center will be the firm’s first dedicated healthcare research center and is se... Read More

© 2019 Fractovia. All Rights Reserved